Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 576 Records) |
| Query Trace: Melanoma and BRAF[original query] |
|---|
| COMBI-r: A Prospective, Non-Interventional Study of Dabrafenib Plus Trametinib in Unselected Patients with Unresectable or Metastatic BRAF V600-Mutant Melanoma. Cancers 2023 9 15 (18): . Carola Berking, Elisabeth Livingstone, Dirk Debus, Carmen Loquai, Michael Weichenthal, Ulrike Leiter, Felix Kiecker, Peter Mohr, Thomas K Eigentler, Janina Remy, Katharina Schober, Markus V Heppt, Imke von Wasielewski, Dirk Schadendorf, Ralf Gutzm |
| Genomic and tumour microenvironmental biomarkers of immune checkpoint inhibitor response in advanced Taiwanese melanoma. Clinical & translational immunology 2023 8 12 (8): e1465. John Wen-Cheng Chang, Chien-Jung Huang, Wen-Kuan Huang, Yu-Chao Wang, Jia-Juan Hsieh, Yao-Yu Chang, Yen-Lin Huang, Chia-Ling Wu, Yeh-Han Wang, Shu-Jen Chen, Kien Thiam Tan, Chiao-Ping Chen, Chiao-En |
| Clinical significance of genetic profiling based on different anatomic sites in patients with mucosal melanoma who received or did not receive immune checkpoint inhibitors. Cancer cell international 2023 8 23 (1): 187. Hai-Yun Wang, Ye Liu, Ling Deng, Kuntai Jiang, Xin-Hua Yang, Xiao-Yan Wu, Kai-Hua Guo, Fang Wa |
| A real-world study of adjuvant anti-PD -1 immunotherapy on stage III melanoma with BRAF, NRAS, and KIT mutations. Cancer medicine 2023 7 . Wei Sun, Yu Xu, WangJun Yan, ChunMeng Wang, Tu Hu, ZhiGuo Luo, XiaoWei Zhang, Xin Liu, Yong Ch |
| Response to high dose ipilimumab plus temozolomide after progression on standard or low dose ipilimumab in advanced melanoma: a retrospective analysis. Research square 2023 7 . Julie Williamson, Muhammad Zaki Hidayatullah Fadlullah, Magdalena Kovacsovics-Bankowski, Berit Gibson, Umang Swami, Alyssa Erickson-Wayman, Debra Jamison, Dan Sageser, Joanne Jeter, Tawnya Bowles, Donald M Cannon, Ben Haaland, Joyce D Schroeder, David Nix, Aaron Atkinson, John Hyngstrom, Jordan McPherson, Aik-Choon Tan, Siwen Hu-Lieskov |
| Distinct senescence mechanisms restrain progression of dysplastic nevi. bioRxiv : the preprint server for biology 2023 7 . Franziska K Lorbeer, Gabrielle Rieser, Aditya Goel, Meng Wang, Areum Oh, Iwei Yeh, Boris C Bastian, Dirk Hockemey |
| Lack of Influence of Non-Overlapping Mutations in BRAF, NRAS, or NF1 on 12-Month Best Objective Response and Long-Term Survival after Checkpoint Inhibitor-Based Treatment for Metastatic Melanoma. Cancers 2023 7 15 (13): . Alyssa Panning, Wolfram Samlowski, Gabriel Allr |
| Druggable genomic landscapes of high-grade gliomas. Frontiers in medicine 2023 12 10 1254955. Paola Ghanem, Maria Fatteh, David Olayinka Kamson, Archana Balan, Michael Chang, Jessica Tao, Jaishri Blakeley, , Jenna Canzoniero, Stuart A Grossman, Kristen Marrone, Karisa C Schreck, Valsamo Anagnost |
| Identifying survival of pan-cancer patients under immunotherapy using genomic mutation signature with large sample cohorts. Journal of molecular medicine (Berlin, Germany) 2023 11 . Liuchao Zhang, Yuanyuan Wang, Liuying Wang, Meng Wang, Shuang Li, Jia He, Jianxin Ji, Kang Li, Lei C |
| [Efficacy of adjuvant programmed cell death 1 (PD-1) monoclonal antibody immunotherapy in Chinese patients with resected stage ?-? melanoma]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 2023 11 45 (11): 973-980. Z G Ren, Y Xu, Z Z Hua, Z Y Mo, L W Wang, G B Shi, W L Liu, W Sun, B Q Zheng, C M Wang, Y J Jin, Y Ch |
| Targeted next-generation sequencing of Japanese patients with sinonasal mucosal melanomas identifies frequent NRAS and CTNNB1 mutations. Auris, nasus, larynx 2023 11 . Nayuta Tsushima, Satoshi Kano, Kanako C Hatanaka, Takayoshi Suzuki, Seijiro Hamada, Hiroshi Idogawa, Yuji Nakamaru, Masanobu Suzuki, Yutaka Hatanaka, Akihiro Hom |
| Effectiveness of Immune Checkpoint Inhibitor with Anti-PD-1 Monotherapy or in Combination with Ipilimumab in Younger versus Older Adults with Advanced Melanoma. Current oncology (Toronto, Ont.) 2023 10 30 (10): 8936-8947. Taylor E Woo, Igor Stukalin, Philip Q Ding, Siddhartha Goutam, Michael Sander, Benjamin Ewanchuk, Winson Y Cheung, Daniel Y C Heng, Tina Che |
| The impact of genomic context on outcomes of solid cancer patients treated with genotype-matched targeted therapies: a comprehensive review. Annals of oncology : official journal of the European Society for Medical Oncology 2023 10 . T Fulton-Ward, G Middlet |
| Impact of Posaconazole and Diltiazem on Pharmacokinetics of Encorafenib, a BRAF V600 Kinase Inhibitor for Melanoma and Colorectal Cancer with BRAF Mutations. Clinical and translational science 2023 10 . Erik Hahn, Renae Chavira, Lance Wollenberg, Weiwei Tan, Micaela B Red |
| Genomic landscape of cutaneous, acral, mucosal, and uveal melanoma in Japan: analysis of clinical comprehensive genomic profiling data. International journal of clinical oncology 2024 9 . Tokimasa Hida, Junji Kato, Masashi Idogawa, Takashi Tokino, Hisashi Uha |
| Genetic Analysis of Melanoma Types Using Japanese Genomic Database. The Laryngoscope 2024 8 . Hayato Matsumoto, Hiromi Nagano, Takayuki Kyutoku, Masaru Yamashi |
| Hotspot Exon 15 Mutations in BRAF Are Uncommon in Feline Tumours. Veterinary and comparative oncology 2024 7 . Kei Kuroki, Christine Tran Hoang, Anita M Rogic, Hans Rindt, Angelynn Simenson, Lucie G Noall, Jeffrey N Bryan, Gayle C Johnson, Shirley C |
| Shortened progression free and overall survival to immune-checkpoint inhibitors in BRAF-, RAS- and NF1- ("Triple") wild type melanomas. European journal of cancer (Oxford, England : 1990) 2024 7 208 114208. Philipp Jansen, Wolfgang Galetzka, Georg C Lodde, Fabian Standl, Anne Zaremba, Rudolf Herbst, Patrick Terheyden, Jochen Utikal, Claudia Pföhler, Jens Ulrich, Alexander Kreuter, Peter Mohr, Ralf Gutzmer, Friedegund Meier, Edgar Dippel, Michael Weichenthal, Jan-Malte Placke, Jennifer Landsberg, Inga Möller, Antje Sucker, Annette Paschen, Eva Hadaschik, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Selma Ugurel, Andreas Stang, Klaus G Griewa |
| Primary Tumor Characteristics as Biomarkers of Immunotherapy Response in Advanced Melanoma: A Retrospective Cohort Study. Cancers 2024 7 16 (13): . Rachel S Goodman, Seungyeon Jung, Kylie Fletcher, Hannah Burnette, Ismail Mohyuddin, Rebecca Irlmeier, Fei Ye, Douglas B Johns |
| Feasibility and Impact of Embedding an Extended DNA and RNA Tissue-Based Sequencing Panel for the Routine Care of Patients with Advanced Melanoma in Spain. International journal of molecular sciences 2024 7 25 (13): . Natalia Castrejon, Roberto Martin, Antonio Carrasco, Paola Castillo, Adriana Garcia, Raquel Albero-González, Mireia García, Marta Marginet, Núria Palau, Mónica Hernández, Carla Montironi, Guillem Clot, Ana Arance, Llucia Alos, Cristina Teixi |
| Adjuvant treatment with anti-PD-1 in acral melanoma: A nationwide study. International journal of cancer 2024 6 . Manja Bloem, Olivier J van Not, Maureen J B Aarts, Franchette W P J van den Berkmortel, Christian U Blank, Willeke A M Blokx, Marye J Boers-Sonderen, Johannes J Bonenkamp, Jan-Willem B de Groot, John B Haanen, Geke A P Hospers, Ellen W Kapiteijn, Melissa M de Meza, Djura Piersma, Rozemarijn S van Rijn, Marion A M Stevense-den Boer, Astrid A M van der Veldt, Gerard Vreugdenhil, Alfons J M van den Eertwegh, Karijn P M Suijkerbuijk, Michel W J M Woute |
| Clinical and genetic characteristics of BAP1-mutated non-uveal and uveal melanoma. Frontiers in immunology 2024 6 15 1383125. Johanna Matull, Jan-Malte Placke, Georg Lodde, Anne Zaremba, Jochen Utikal, Patrick Terheyden, Claudia Pföhler, Rudolf Herbst, Alexander Kreuter, Julia Welzel, Julia Kretz, Inga Möller, Antje Sucker, Annette Paschen, Elisabeth Livingstone, Lisa Zimmer, Eva Hadaschik, Selma Ugurel, Dirk Schadendorf, Carl Maximilian Thielmann, Klaus Georg Griewa |
| Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma. The New England journal of medicine 2024 6 . Georgina V Long, Axel Hauschild, Mario Santinami, John M Kirkwood, Victoria Atkinson, Mario Mandala, Barbara Merelli, Vanna Chiarion Sileni, Marta Nyakas, Andrew Haydon, Caroline Dutriaux, Caroline Robert, Laurent Mortier, Jacob Schachter, Dirk Schadendorf, Thierry Lesimple, Ruth Plummer, James Larkin, Monique Tan, Sachin Bajirao Adnaik, Paul Burgess, Tarveen Jandoo, Reinhard Dumm |
| Real-world efficacy and safety of BRAF-targeted therapy for patients with advanced melanoma: A single-center retrospective study in Japan. The Journal of dermatology 2024 5 . Eiji Nakano, Akira Takahashi, Dai Ogata, Kenjiro Namikawa, Naoya Yamaza |
| [Dramatic response to encorafenib plus binimetinib in a patient with leukemoid reaction from metastatic melanoma.]. Recenti progressi in medicina 2024 5 115 (5): 13e-16e. Marianna Cerro, Maria Teresa Maccallini, Michelangelo Russil |
| The immune response-related genomic alterations in patients with malignant melanoma. Medicine 2024 4 103 (17): e37966. Linqing Li, Tianmin Xiang, Xianan |
| Mutational landscape of oral mucosal melanoma based on comprehensive cancer genomic profiling tests in a Japanese cohort. Oral oncology 2024 4 152 106807. Norihisa Ichimura, Yusuke Urata, Takeru Kobayashi, Hideharu Hi |
| Targeted DNA Sequencing of Cutaneous Melanoma Identifies Prognostic and Predictive Alterations. Cancers 2024 4 16 (7): . Alexandra M Haugh, Robert C Osorio, Rony A Francois, Michael E Tawil, Katy K Tsai, Michael Tetzlaff, Adil Daud, Harish N Vasudev |
| Low incidence of BRAF and NRAS mutations in a population with a high incidence of melanoma. Virchows Archiv : an international journal of pathology 2024 1 . Grace Neville, Barbara Marzario, David Shilling, Collette K Hand, Cynthia Heffr |
| Incidence of BRAF mutations in cutaneous melanoma: histopathological and molecular analysis of a Ukrainian population. Melanoma management 2024 1 10 (1): MMT64. Oleksandr Dudin, Ozar Mintser, Nazarii Kobyliak, Dmytro Kaminskyi, Roman Shabalkov, Alina Matvieieva, Olga Sukhanova, Antonina Kalmykova, Denys Kozakov, Artem Mashukov, Oksana Sulaie |
- Page last reviewed:Feb 1, 2024
- Content source: